Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
JAGX
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Jaguar Health, Inc. Announces Reverse Stock Split
Reverse split approved at April 2026 Special Meeting of Stockholders Shares of Jaguar Health common stock to begin trading on split-adjusted basis on September 17, 2026 SAN FRANCISCO, CA / ACCESS Newswire / September 15, 2026 / Jaguar Heal…
Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs Jaguar expects Ne…
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs Jaguar expects to…
Jaguar Health targets mid-2027 MVID NDA filing with possible end-2027 U.S. approval, backed by up to 48% parenteral support reductions
Earnings Call Insights: Jaguar Health (JAGX) Q2 2026 MANAGEMENT VIEW * CEO Lisa Conte framed Q2 around “transformation, near-term catalysts and sharp strategic focus,” saying that after the January 2026 Future Pak out-license, “we are now…
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs Jaguar expects to…
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now availabl…
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
Emerging Growth MIAMI, June 09, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 93rd Emerging Growth Conference on June 10 & 11, 2026. The Emerging Growth Conference id…
Image source: The Motley Fool. DATE Nov. 17, 2025, 9 a.m. ET CALL PARTICIPANTS Founder, President, and Chief Executive Officer — Lisa Conte Chief Financial Officer — Carol Lizak Need a quote from a Motley Fool analyst? Email pr@fool.com Fu…
Image source: The Motley Fool. Date Friday, April 10, 2026 at 7 a.m. ET Call participants Founder, President, and Chief Executive Officer — Lisa Conte Chief Financial Officer — Carol Lizak Full Conference Call Transcript Jaguar believes th…
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
Reverse split approved at April 2026 Special Meeting of Stockholders Shares of Jaguar Health common stock to begin trading on split-adjusted basis on April 30, 2026 SAN FRANCISCO, CA / ACCESS Newswire / April 27, 2026 / Jaguar Health, Inc.…
Jaguar Health Plans To Adopt AI Platform For Crofelemer In Treating Intestinal Failure
(RTTNews) - Jaguar Health Inc. (JAGX), a commercial-stage pharmaceutical company, announced plans to use artificial intelligence (AI) platforms for the advancement of Crofelemer in treating intestinal failure (IF) in adults and children. T…
* Jaguar Health press release [https://seekingalpha.com/pr/20464980-jaguar-health-reports-2025-financials] (JAGX [https://seekingalpha.com/symbol/JAGX]): Q4 Revenue of $3.2M (-8.6% Y/Y). * Net loss attributable to common shareholders incre…
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Virtual Investor Conferences NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, h…
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are no…
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Virtual Investor Conferences Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary inve…
FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Conditional approval extended through December 2026 for the treatment of CID in dogs CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA's June deadline - 51 dogs enrolled to date; ~49 more expected SAN…
Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live stream
MIAMI, Dec. 10, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 88th Emerging Growth Conference on December 10 & 11, 2025. The Emerging Growth Conference identifies com…
Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live stream
Emerging Growth MIAMI, Dec. 10, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 88th Emerging Growth Conference on December 10 & 11, 2025. The Emerging Growth Conferenc…
Jaguar Health outlines dual NDA filing targets for late 2026 as clinical catalysts converge
Earnings Call Insights: Jaguar Health (JAGX) Q3 2025 MANAGEMENT VIEW * Lisa Conte, Founder, CEO, President & Director, highlighted that combined net third quarter 2025 revenue of approximately $3.1 million for prescription and nonprescript…
Jaguar Health registers 2.62M shares for resale following private placements
* Jaguar Health (NASDAQ:JAGX [https://seekingalpha.com/symbol/JAGX]) registered 2.62M shares of common stock for resale by existing stockholders. * Includes 1.98M shares issuable upon exchange of 950.8 shares of Series N Preferred Stock. *…
Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream
MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifies c…
Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream
MIAMI, Sept. 23, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifies c…
Jaguar Health, Inc. (NASDAQ:JAGX) is among the best fundamentally strong penny stocks to buy right now. On September 9, 2025, Jaguar Health, Inc. (NASDAQ:JAGX) signed securities purchase agreements with some investors for the issuance and…
Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream
MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025. The Emerging Growth Conference identifies compa…
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream
MIAMI, Aug. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025. The Emerging Growth Conference identifies compa…
Jaguar Health extends Lucid Capital Markets role in ATM agreement to year-end
Jaguar Health, Inc. (NASDAQ:JAGX), a pharmaceutical company with a market capitalization of $4.3 million and significant debt burden of $38.3 million, announced Thursday that it has amended its At the Market Offering Agreement to extend th…
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals a…
Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream
MIAMI, July 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies compani…
Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream
MIAMI, July 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies compani…
Jaguar Health files to sell 507.4K shares of common stock by selling shareholders
* Jaguar Health (JAGX [https://seekingalpha.com/symbol/JAGX]) filed a prospectus to resale 507.4K shares of common stock. * The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder. * This prosp…
Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 83rd Emerging Growth Conference on June 17 & 18, 2025. The Emerging Growth Conference identifies compani…
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies companies…
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream
MIAMI, May 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies companies…
Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now
MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 80th Emerging Growth Conference on March 26 & 27, 2025. The Emerging Growth Conference identifies com…
Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now
Emerging Growth MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 80th Emerging Growth Conference on March 26 & 27, 2025. The Emerging Growth Conferenc…